life scienc tool diagnost
price month
ep exce consensu idxx ep
beat estimate slightli weaker revenu off-set higher profit
factor line ad temper organ
revenu guidanc bp reflect latest perform rais
ep guid midpoint fulli reflect beat lower
tax rate oper improv partial off-set fx
importantli strong recur revenu expect
unchang rais ep
reflect latest upsid lower tax rate off-set slightli lower
revenu profit trajectori balanc year tp move
higher view
share may ebb st follow out-performance encourag
sustain strength all-import organ recur revenu
aspir continu strength balanc year
idxx share ytd vs view share may eas
softer organ revenu experi revis top-line guid
said would emphas call greater cc oper profit
expans bp vs previou bp midpoint
admittedli focu investor underscor multipl
profit lever view compel altern hc invest
strong recur revenu consist price realiz healthi
fundament backdrop contribut greater predict visibl
 close
valuat metric
number share
suiss seek busi compani cover research report result investor awar
firm may conflict interest could affect object report investor consid report
singl factor make invest decis
price jul rate outperform target price analyst erin wright
profit tax
chang work capit
flow oper
free cash-flow firm
flow invest
chang net cash/debt
total liabil equiti
share wtd average
price book
roe stated-return
global leader diagnost point-of-car equip
refer laboratori servic companion anim also
provid system diagnost livestock water qualiti
share gain refer laboratori point-of-car acceler
global expans greater contribut innov new product
launch technolog advanc greater expect
growth broader anim health industri fundament
stronger expect macroeconom fx headwind
increasingli global footprint less adoption/tract futur product
launch deterior veterinari health fundament
 close
sustain strength recur profit prevail report
revenu estim organ growth vs estimate
vs estimate driven us ou still
impress consum albeit slightli plan estimate note
product cycl dynam catalyst placement declin driven ou
ref lab modestli plan ou anticip soft
spot new sale initi off-set dd us rapid vs estimate
bright spot despit inher competit segment vs
also higher off-set lpd flat vs asf headwind gross margin rose
bp mix/pric op expens fell bp bp plan contribut
ebit margin expans bp bp plan flow million
help fund million share repurchas reserv stand
compani mention price
erin wilson wright certifi view express report accur reflect person view subject compani
secur part compens directli indirectli relat specif recommend view express
report
